The EACR conference The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities was held between 19-21 March 2024 in Bergamo, Italy and brought together 227 delegates from 33 countries. This EACR conference aimed to explore the dynamics of the tumour microenvironment, in order to achieve a comprehensive, integrated understanding of reciprocal cancer/stroma interactions, and how they are modulated by cancer treatments. To this aim research insights into how the stromal and the immune cells shape the tumour microenvironment, changes in cell metabolism, organ-specific characteristic ..read more

Magdalena Sznurkowska and Irene Casanova Salas have been announced as the 2024 recipients of EACR-AstraZeneca Postdoctoral Fellowships, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe and the world. Jane Smith, Chief Executive Officer at the EACR, says, “It is a pleasure to offer warm congratulations to Magda and Irene. We are delighted that they both will be joining us at our congress in Rotterdam in June to tell us more about their research, and we wish them all the very best as they embark on their Fel ..read more

On 13-14 February, the EACR held our virtual conference, Signaling Circuits in Cancer, where over a hundred scientists from 28 countries gathered to discuss our global understanding of how cancer cell signaling circuits are controlled, and how they determine cancer progression and therapy resistance. In case you missed it, the EACR’s Scientific Officer, Dr. Alexandra Boitor, shares here the scientific highlights. Kinases and phosphatases: from cancer progression to drug development Two focal points for discussion during the conference were the CDK and the MAPK/ERK pathways. The emerging role o ..read more

Colin Ratcliffe has now completed his first year of his EACR-AstraZeneca Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe and the world. Colin is a postdoctoral fellow in Erik Sahai’s laboratory at the Francis Crick Institute in the UK. We recently caught up with him to hear about the progress he has made in his research during this first year. Can you tell us about the topic of the research you are undertaking during your fellowship? My overall research goal is to understand the r ..read more

Horizon Europe widening funds are distributed to address inequity in research and innovation capacities across Europe, allowing the EU as a whole to advance together, in line with the policy objectives of the European Research Area. Although various Areas of intervention exist, their full potential is yet to be exploited. During the previous program, Horizon 2020, widening measures have triggered advanced reforms and changes, increasing the number of new partnerships thus leading to more peer reviewed international publications following Open Science principles. Researchers from non-western Eu ..read more

Dr. Alexandra Boitor, EACR Scientific Officer, writes about her experience and scientific highlights from Cellular Bases for Patient Response to Cancer Therapies, which was held between 14 – 16 November 2023. Participants from 27 countries joined us at the Centre de Congrès de Lyon in France. The conference had a focus on improving the understanding of how traditional anti-cancer therapy works. By uncovering previously unknown modes of action and cellular effects of conventional cancer treatments such as chemotherapy and hormone therapy, these discoveries have the potential to revolutioni ..read more

We are delighted to announce that Stamatis Papathanasiou has been selected as the recipient of the 2024 EACR-Mark Foundation-Pezcoller Foundation Rising Star Award. This prestigious award, launched in 2023, recognises an exceptional cancer researcher each year and aims to support groundbreaking projects that have the potential to make significant contributions to the field. 2024 Rising Star Award winner, Stamatios Papathanasiou Stamatis Papathanasiou, Group Leader at The Institute of Molecular Biology (IMB), in Mainz, Germany, was chosen for this award based on the high quality of his project ..read more

Researchers attend conferences, courses and workshops to build their knowledge, gain new skills and share their findings, but obtaining funding to attend events can be very difficult, especially for researchers based in low- and middle-income countries (LMIC). That’s why we have recently trialled a new programme to offer EACR Researcher Development Grants. We have now awarded 14 of these grants to help EACR members based in countries with a low- or middle-income economy who need financial assistance to attend a workshop, course or conference that will support their career development and resea ..read more

Dr. Alexandra Boitor, EACR Scientific Officer, writes about her experience and scientific highlights from the EACR Conference ‘Goodbye Flat Biology’, which was held in Berlin, Germany from 10-12 October 2023. Traditionally, the EACR Goodbye Flat Biology conferences focus on the next generation of cancer models that more accurately reflect the biochemical, spatial, and mechanical properties of tumours in their tissue environment. This year was no exception and talks at the conference covered a range of novel technical approaches to modelling cancer. From modelling tumours to understanding cell ..read more

We were delighted to welcome the cancer research community to Torino, Italy for the EACR Annual Congress 2023: Innovative Cancer Science between 12 – 15 June 2023. We enjoyed a jam-packed programme of fascinating science with a range of Plenary sessions, Symposia, Meet the Expert panels and Educational Sessions. We saw 2,100+ participants from 65 countries come through the Lingotto Fiere venue doors, of whom 98% told us in our feedback survey that they would recommend the Congress. Thank you so much to everyone who joined us! This year’s programme included six keynote lectures, including a ta ..read more